Ticker: UNH

UnitedHealth

Healthcare Healthcare Medical - Healthcare Plans

Price 407.10

Reco Buy Potential 79 Risk 32 Updated 2026-10-27

Official website

Forecast impact

positive

Target +29.4% target fill 77.3%

Reaction D5 pending · D10 pending fresh confirmed · market trust

Impact Potential +6 · Risk -3 valid until 2026-11-26

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

UnitedHealth Group Incorporated operates in the healthcare sector, providing a range of health insurance products and services. Its core offerings include health benefits, health services, and pharmacy care. The company operates through two major segments: UnitedHealthcare, which focuses on health insurance, and Optum, which provides health services and technology solutions. Main revenue sources include premiums from health plans and fees for services rendered through its various health service operations.

Investment Profile

The investment profile of UnitedHealth is more aligned with balanced investors, given its combination of growth potential and a moderate dividend yield. The company demonstrates solid earnings performance and a stable market position, appealing to those seeking both capital appreciation and income. Its relatively low volatility suggests a lower risk profile, making it suitable for a medium to long-term investment horizon.

Category: Healthcare Sector: Healthcare Industry: Medical - Healthcare Plans Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-25

EPS (TTM) — earnings per share for the last 12 months, $: 17.52
Revenue QoQ — quarter-over-quarter revenue growth: 0.6%
EPS surprise: 13.3%
20d volatility: 1.7%
Dividend yield: 2.3%
last ex-date: 2026-09-14

AI recommendation changes

Date	Before	After	Reason
2026-10-21	Hold	Buy	Strong performance and solid fundamentals support growth potential.
2026-10-09	Sell	Hold	Weak momentum and mixed fundamentals suggest caution.
2026-10-01	Hold	Sell	Weak momentum and high risk; cautious approach advised.
2026-09-24	Buy	Hold	Weak momentum and high risk; hold for now.
2026-09-22	Hold	Buy	Solid fundamentals, but recent momentum is concerning.
2026-09-17	Buy	Hold	Weak momentum and high risk; cautious approach advised.
2026-09-15	Hold	Buy	Strong fundamentals but recent negative momentum concerns.
2026-09-11	Buy	Hold	Mixed performance; high risk with uncertain momentum.
2026-08-22	Hold	Buy	Strong fundamentals, but recent negative momentum concerns.
2026-08-20	Buy	Hold	Weak momentum and high risk; hold for now.
2026-08-16	Hold	Buy	Strong fundamentals, but recent momentum is concerning.
2026-08-14	Buy	Hold	Weak momentum and high risk; hold for now.
2026-05-08	—	Buy	Strong fundamentals and positive momentum support growth outlook.
2026-05-08	Buy	Buy	Компания демонстрирует сильный рост за последние 20 и 60 дней, а также стабильный дивидендный доход. Низкий риск и положительная динамика прибыли делают акции привлекательными для инвестиций.
2026-04-30	Hold	Buy	Компания показывает устойчивый рост с положительной динамикой за последние 20 и 60 дней, а также имеет стабильный дивидендный доход. EPS и высокая степень неожиданности по отчетности указывают на сильные финансовые показ
2026-04-23	Buy	Hold	Компания показывает сильный рост за последние 5 и 20 дней, а также стабильный дивидендный доход. Низкий риск и положительная динамика EPS делают её привлекательной для инвестиций.
2026-04-15	Hold	Buy	Компания показывает стабильный рост выручки и дивидендную доходность, однако недавние колебания цен на акции и негативная динамика за 60 и 120 дней вызывают осторожность.
2026-04-05	Sell	Hold	Компания демонстрирует стабильные финансовые показатели, однако недавнее снижение цен акций и высокая волатильность указывают на значительные риски. Рекомендуется удерживать акции до более ясной картины на рынке.
2026-03-27	Hold	Sell	Компания демонстрирует негативную динамику акций за последние месяцы, что указывает на высокие риски. Однако стабильный дивиденд и умеренный рост выручки могут поддерживать интерес инвесторов.
2026-02-22	Buy	Hold	Компания показывает умеренные колебания цен и стабильный дивидендный доход, однако недавнее снижение на 18.19% за 20 дней вызывает опасения.
2026-02-14	Hold	Buy	Компания показывает стабильный рост выручки и дивидендную доходность, однако недавние колебания цен указывают на возможные риски в краткосрочной перспективе.
2026-01-29	Buy	Hold	Несмотря на недавнее падение акций, компания демонстрирует стабильный рост выручки и EPS. Дивидендная доходность также привлекательна, что делает акцию интересной для удержания.
2026-01-21	Hold	Buy	Компания показывает стабильный рост выручки и EPS, а также имеет привлекательную дивидендную доходность. Несмотря на недавние колебания, долгосрочные показатели указывают на сильный потенциал роста.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-27	Morgan Stanley	Target Raised	529 → 531	410.7
2026-10-27	Wells Fargo	Target Lowered	— → 487	410.7
2026-10-22	Mizuho Securities	Target Raised	493 → 500	417
2026-10-20	RBC Capital	Target Raised	— → 498	406.88
2026-10-16	H.C. Wainwright	Target Lowered	— → 500	400.645
2026-10-16	Stephens	Target Lowered	— → 500	400.645
2026-10-16	Bernstein	Target Lowered	512 → 500	406.67
2026-10-15	Raymond James	Target Lowered	— → 450	395.62
2026-10-14	Robert W. Baird	Target Lowered	453 → 427	377.76
2026-10-14	Piper Sandler	Target Raised	502 → 504	377.76
2026-10-14	Barclays	Target Lowered	441 → 440	377.76
2026-10-09	New Street	Target Lowered	— → 402	370.95
2026-07-21	BMO Capital	Target Raised	— → 512	430.915
2026-07-21	D.A. Davidson	Target Raised	— → 512	430.915
2026-07-20	Mizuho Securities	Target Raised	— → 493	421.55
2026-07-20	Wells Fargo	Target Raised	485 → 526	426.09
2026-07-20	Barclays	Target Raised	429 → 441	426.09
2026-07-17	Truist Financial	Target Raised	480 → 500	429.39001
2026-07-17	UBS	Target Raised	460 → 490	423.38
2026-07-17	Morgan Stanley	Target Raised	468 → 529	423.38
2026-07-17	KeyBanc	Target Raised	475 → 500	423.38
2026-07-16	Robert W. Baird	Rating Upgraded	— → 453	429.43
2026-07-16	Piper Sandler	Target Raised	— → 477	446.715
2026-07-15	Piper Sandler	Target Raised	420 → 475	419.23
2026-07-14	Truist Financial	Target Raised	440 → 480	429.09
2026-07-14	KeyBanc	Target Raised	400 → 475	429.09
2026-07-13	Wells Fargo	Target Raised	397 → 485	424.62
2026-07-09	RBC Capital	Target Raised	400 → 463	433.88
2026-07-06	HSBC	Target Raised	300 → 380	415.74
2026-06-30	Morgan Stanley	Target Raised	— → 468	419.82
2026-06-17	Leerink Partners	Target Raised	— → 462	407.65
2026-06-08	Mizuho Securities	Target Raised	440 → 460	399.47
2026-06-04	Morgan Stanley	Target Raised	395 → 453	377
2026-06-01	Truist Financial	Target Raised	395 → 440	380.31
2026-05-27	H.C. Wainwright	Target Raised	— → 492	376.86
2026-05-27	Bernstein	Target Raised	444 → 492	376.86
2026-05-26	Barclays	Target Raised	373 → 429	378.99
2026-05-22	UBS	Target Raised	410 → 460	382.48
2026-05-20	Mizuho Securities	Target Raised	410 → 440	389.24
2026-05-01	Goldman Sachs	Update	— → 435	370.48
2026-04-20	Jefferies	Target Raised	340 → 373	324.63
2026-02-02	Truist Financial	Target Lowered	410 → 370	287.2
2026-01-30	Wells Fargo	Target Lowered	400 → 370	292.29
2026-01-30	Barclays	Target Lowered	391 → 327	292.29

News Page 2 of 2

United Airlines Reports Mixed Earnings Amid Rising Fuel Costs, While UnitedHealth Exceeds Expectations and Raises Profit Outlook

07/16/2026, 05:36 AM economy review finance healthcare UnitedHealth United Airlines

Recent economic indicators suggest a potential easing of inflation, which could influence Federal Reserve interest rate decisions. Additionally, United Airlines faces rising fuel costs despite beating earnings expectations, while UnitedHealth's strong performance and Anthropic's IPO preparations highlight significant movements in the healthcare and tech sectors.

Stocks Making Significant Moves Premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt, and More

07/16/2026, 05:36 AM business review General Electric UnitedHealth Taiwan Semiconductor Manufacturing Company Atai Life Sciences Rocket Companies J.B. Hunt Transport Services AeroVironment Eli Lilly

Premarket trading saw significant movements, particularly for UnitedHealth and AtaiBeckley, which reported strong earnings and acquisition news, respectively, impacting investor sentiment and stock valuations.

UnitedHealth Group Reports Strong Q2 Earnings, Raises Full-Year Profit Outlook Amid Cost Management Efforts

07/16/2026, 03:35 AM business forecast healthcare UnitedHealth

UnitedHealth Group's strong second-quarter earnings and raised profit outlook highlight its effective cost management and AI integration, signaling potential growth despite ongoing challenges in the healthcare sector.

Earnings Season Begins with Major Reports from JPMorgan Chase, Goldman Sachs, and Netflix

07/12/2026, 05:31 AM investing review JPMorgan Chase Goldman Sachs UnitedHealth Johnson & Johnson Netflix Morgan Stanley Bank of America

This week marks a significant earnings reporting period for nearly 28 S&P 500 companies, including major banks and Netflix, as investors closely monitor performance amid high market expectations and potential Federal Reserve interest rate changes.

Analysts Raymond James add UnitedHealth Group (UNH) and Janus Living (JAN) to top healthcare picks amid sector rally

07/02/2026, 12:36 PM investing recommendation Analysts: analysts, Raymond James healthcare UnitedHealth

Raymond James has identified two healthcare stocks, UnitedHealth Group and Janus Living, as top picks due to their strong performance and attractive dividends, reflecting a broader shift in investor interest towards the healthcare sector amidst a challenging tech market.

Dow Jones Industrial Average Hits Record High as Health-Care Stocks Lead Market Gains

06/05/2026, 05:34 AM business review healthcare UnitedHealth Humana Centene Eli Lilly

Despite a decline in chip stocks, the U.S. stock market saw significant gains, with the Dow Jones Industrial Average reaching a new record, driven largely by strong performance in the health-care sector.

Analysts Bank of America upgraded UnitedHealth Group (UNH) to Buy and raised target price to $450 (upside +19%)

06/04/2026, 06:31 AM investing rating_growth Analysts: analysts, Bank of America healthcare UnitedHealth

Bank of America has upgraded UnitedHealth Group to a buy rating, citing the company's successful strategic shifts that are expected to enhance earnings and boost share prices significantly.